Makaleler
Tümü (12)
SCI-E, SSCI, AHCI (11)
SCI-E, SSCI, AHCI, ESCI (12)
ESCI (1)
Scopus (11)
TRDizin (1)
2016
20161. Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-alpha Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence
Kisacik B., Pamuk O. N., Onat A. M., Erer S. B., Hatemi G., Ozguler Y., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.43, sa.3, ss.524-529, 2016 (SCI-Expanded, Scopus)
2015
20152. Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A
KALYONCU U., Emmungil H., Onat A. M., Yilmaz S., Kasifoglu T., Akar S., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY
, cilt.2, sa.4, ss.149-154, 2015 (ESCI, TRDizin)
2015
20153. The Effect of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Positivity on Drug Survival of Abatacept in Patients with Rheumatoid Arthritis in Routine Care: The Results from Turkbio Registry
Ertenli I., KARADAĞ Ö., PEHLİVAN Y., Dalkilic E., Onat A. M., Kisacik B., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
2014
20144. Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.
Kisacik B., Pamuk O., Onat A. M., Erer B., Hatemi G., Ozguler Y., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.66, 2014 (SCI-Expanded, Scopus)
2014
20145. Mean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic Sclerosis
Soydinc S., Turkbeyler I. H., PEHLİVAN Y., Soylu G., Goktepe M. F., Bilici M., et al.
INFLAMMATION
, cilt.37, sa.1, ss.100-106, 2014 (SCI-Expanded, Scopus)
2014
20146. The Comparative One-Year Drug Survival Rate of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis; Results from Turkbio Registry
Sari I., KALYONCU U., Onat A. M., Pamuk O. N., KARADAĞ Ö., Kisacik B., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.32, sa.4, 2014 (SCI-Expanded, Scopus)
2013
20137. Is familial Mediterranean fever (FMF) common in patients with negative appendectomy?
Kisacik B., Karabicak I., Erol M. F., Ozer S., Pehlivan Y., Onat A. M., et al.
MODERN RHEUMATOLOGY
, cilt.23, sa.2, ss.330-333, 2013 (SCI-Expanded, Scopus)
2009
20098. Detecting Subclinical Biventricular Impairment in Scleroderma Patients by Use of Pulsed-Wave Tissue Doppler Imaging
Can I., Onat A. M., AYTEMİR K., AKDOĞAN A., Ureten K., KİRAZ S., et al.
TEXAS HEART INSTITUTE JOURNAL
, cilt.36, sa.1, ss.31-37, 2009 (SCI-Expanded, Scopus)
2007
20079. Cardiac repolarization abnormalities and increased, sympathetic activity in scleroderma
Ciftci O., Onat A. M., Yavuz B., Akdogan A., Aytemir K., Tokgozoglu L., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.99, sa.3, ss.232-237, 2007 (SCI-Expanded, Scopus)
2007
200710. Selective serotonin reuptake inhibitors reduce the attack frequency in familial Mediterranean fever
Onat A. M., Ozturk M. A., Ozcakar L., Ureten K., Kaymak S. U., kiraz S., et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
, cilt.211, sa.1, ss.9-14, 2007 (SCI-Expanded, Scopus)
2006
200611. Sonographic evaluation of the tendons in familial Mediterranean fever and Behcet's disease
Oezcakar L., Onat A. M., Uereten K., Cetin A., Sedat K., Ertenli I., et al.
JOINT BONE SPINE
, cilt.73, sa.5, ss.514-517, 2006 (SCI-Expanded, Scopus)
2005
200512. Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha
ÇALGÜNERİ M., Onat A. M., ÖZTÜRK M. A., Ozcakar L., ÜRETEN K., Akdogan A., et al.
CLINICAL RHEUMATOLOGY
, cilt.24, sa.1, ss.64-66, 2005 (SCI-Expanded, Scopus)